Key result
Early mobilization during ECMO is safe, with <1% serious adverse events.
Why the study?
Prolonged immobility on ECMO precipitates ICU-acquired weakness, diaphragmatic dysfunction, and secondary pulmonary complications, yet the safety profiles, clinical feasibility, and operational protocols of early mobilization and active respiratory physiotherapy during ECMO remain variable and under defined.
Does multi-tiered early mobilization and targeted respiratory physiotherapy improve feasibility, safety, and functional recovery outcomes in adult patients receiving venovenous or venoarterial ECMO support?
Systematic Review
Does multi-tiered early mobilization and targeted respiratory physiotherapy improve feasibility, safety, and functional recovery outcomes in adult patients receiving venovenous or venoarterial ECMO support?
This scoping review of 18 studies demonstrates that early mobilization and respiratory physiotherapy during ECMO are feasible and safe (<1% serious adverse events) when guided by a 4-phase progressive protocol and multidisciplinary team, though high-level ambulation is much more achievable in VV-ECMO than femoral VA-ECMO.
Answers are grounded in this paper and cite their sources.
Supports protocolized early mobilization in ECMO care by trained teams; extends observational safety data but leaves open randomized trials on functional outcomes.
Background: Extracorporeal membrane oxygenation (ECMO) provides life-sustaining support for patients suffering from severe, refractory acute respiratory distress syndrome (ARDS) or cardiogenic shock. Historically, clinical practice mandated deep neuromuscular blockade and continuous sedation to prevent adverse events such as cannula dislodgement, circuit disruption, and hemodynamic collapse. However, prolonged immobility precipitates rapid ICU-acquired weakness (ICUAW), diaphragmatic dysfunction, and secondary pulmonary complications. While early mobilization (EM) and active respiratory physiotherapy are increasingly integrated into critical care to counteract these adverse outcomes, their safety profiles, clinical feasibility, and operational protocols during ECMO remain variable and under defined. Objective: To systematically map the existing clinical literature, establish standardized mobilization and respiratory physiotherapy protocols, evaluate safety profiles, and identify predefined termination criteria for physical rehabilitation in adult patients supported on ECMO. Methods: A comprehensive scoping review was conducted adhering to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. A structured literature search across MEDLINE/PubMed, Embase, CINAHL, and the Cochrane Library identified primary clinical studies published between 2000 and 2025. Studies evaluating early physical mobilization, passive conditioning, active rehabilitation, or specialized respiratory physiotherapy during venovenous (VV) or venoarterial (VA) ECMO support were included. Results: Synthesis of the literature demonstrates that progressive early mobilization and targeted respiratory physiotherapy—spanning from passive range-of-motion (PROM) and neuromuscular electrical stimulation (NMES) to standing, ergometry, and active ambulation—are feasible and clinically safe when executed by a dedicated, trained multidisciplinary team (MDT). Serious adverse events appear to be uncommon in published cohorts, although reported event rates vary across studies and definitions. Available evidence has generally demonstrated low rates of mobilization-related complications, but the heterogeneous reporting of adverse events prevents establishment of a universal incidence threshold. VV-ECMO cohorts demonstrate a significantly higher capacity for high-grade functional mobility (including ambulation) compared to VA-ECMO cohorts. VA-ECMO patients require conservative, lower-intensity modalities due to femoral arterial cannulation constraints, cardiac reserve limitations, and hemodynamic vulnerability. Most reported adverse events were minor, transient, and self-limiting (eg, brief desaturation, temporary postural hypotension, or minor line chattering). Conclusion: Early mobilization and respiratory support during ECMO are feasible and safe, provided they are delivered within structured, multi-tiered safety protocols governed by an MDT. Current literature is primarily limited by observational methodology, heterogeneous reporting, and an absence of standardized safety outcome metrics. Future research must prioritize randomized controlled trials (RCTs) and evaluate long-term functional recovery, quality of life, and post-intensive care syndrome (PICS) outcomes.
No takes yet. Share an insight, caveat, or question.
PT et al. (2026) conducted a systematic review in Severe acute respiratory distress syndrome (ARDS) or cardiogenic shock requiring extracorporeal membrane oxygenation (ECMO). Early mobilization and targeted respiratory physiotherapy vs. Standard ICU care, historical immobilization/deep sedation controls, or VV-ECMO vs VA-ECMO comparisons was evaluated on Feasibility, safety (incidence of major/minor adverse events), and highest level of mobility achieved during ECMO. Early mobilization and respiratory physiotherapy during ECMO are feasible and safe when delivered by a multidisciplinary team, with serious adverse events occurring in <1% of reported cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: